Systemic Anti-Cancer Therapy Data Set

IntroductionThe Systemic Anti-Cancer Therapy Data Set collects clinical management information on PATIENTS undergoing Systemic Anti-Cancer Therapy in (or funded by) the NHS in England.

Overview

Introduction

The Systemic Anti-Cancer Therapy Data Set  collects clinical management information on PATIENTS undergoing  Systemic Anti-Cancer Therapy in (or funded by) the NHS in England.

In the clinical setting its primary use is in prescribing and administering Systemic Anti-Cancer Therapy. The standard also specifies secondary uses information about Systemic Anti-Cancer Therapy which is required to assist in achieving, supporting and monitoring the NHS Operating Framework, specialised commissioning and related policy.

Details of Standard

The Systemic Anti-Cancer Therapy Data Set relates to all cancer PATIENTS, both adult and paediatric, in both admitted  PATIENT care and outpatient and community settings, who are receiving  Systemic Anti-Cancer Therapy  for all solid Tumour and haematological malignancies, including those treated in CLINICAL TRIALS.

The Systemic Anti-Cancer Therapy Data Set  covers the period from the Start Date  of the Systemic Anti-Cancer Therapy Drug Regimen  to the Start Date  of the last Systemic Anti-Cancer Therapy Drug Cycle.

Note: PATIENTS  may end their treatment with an oral or other component taken at home. Although the dispensing of this will be recorded in the final Systemic Anti-Cancer Therapy Drug Cycle, it is not possible to confirm that the PATIENT has taken the medication.

Data Set Structure and Transmission

Systemic Anti-Cancer Therapy is given over a prolonged period of time, often months or years, comprising repeating and sequential elements.  The PATIENT may attend two or more Health Care Providers during the course of treatment.

In order to track the PATIENT during treatment, the data set must be capable of linking all the elements of care in a consistent and ordered way. In order to achieve this, the Systemic Anti-Cancer Therapy Data Set has a branching structure which links the initial data fields, which will remain constant during the treatment, with detail of each Systemic Anti-Cancer Therapy Drug Regimen, Systemic Anti-Cancer Therapy Drug Cycle  and Systemic Anti-Cancer Therapy Drug Administration.  At the completion or cessation of a Systemic Anti-Cancer Therapy Drug Regimen, the outcome section must link back to all previous fields. It must be possible to reconstitute details of each PATIENT's sequential management from the serial downloads received.

All NHS Trusts and NHS Foundation Trusts  providing Systemic Anti-Cancer Therapy Services  are required to submit monthly data downloads to an agreed timetable, two months in arrears. These data must represent all treatment activity in the month period, including Systemic Anti-Cancer Therapy Drug Regimens started and completed or ceased in the REPORTING PERIOD.

The data repository is hosted by the National Cancer Registration and Analysis Service  (NCRAS) and the data is held under their section 251 of the National Health Service Act 2006.

Data downloads is by csv and will uniquely identify the Health Care Provider.

Further Guidance

Detailed technical guidance on the processes required, and any required updates, is available from the National Cancer Registration and Analysis Service  in the Technical Guidance documents supporting the programme.

Mandation

The Mandation column indicates the recommendation for the inclusion of data.

  • M = Mandatory: this data element is mandatory and the technical process (e.g. submission of the data set, production of output etc) cannot be completed without this data element being present

  • R = Required: NHS business processes cannot be delivered without this data element

  • O = Optional: the inclusion of this data element is optional as required for local purposes

  • P = Pilot: this data element is for piloting use only.

Data Set Constraints

For guidance on the Data Set constraints, see the Systemic Anti-Cancer Therapy Data Set Constraints.

Specification

DEMOGRAPHICS AND CONSULTANT

To carry details for the demographics and consultant.Oneoccurrence of this group is required.

Mandation

Data Elements

M

NHS NUMBER

Or

LOCAL PATIENT IDENTIFIER (EXTENDED)

M

NHS NUMBER STATUS INDICATOR CODE

M

PERSON FAMILY NAME

M

PERSON GIVEN NAME

M

PERSON BIRTH DATE

R

PERSON STATED GENDER CODE

M

POSTCODE OF USUAL ADDRESS

R

CONSULTANT CODE (INITIATED SYSTEMIC ANTI-CANCER THERAPY)

R

CARE PROFESSIONAL MAIN SPECIALTY CODE (START SYSTEMIC ANTI-CANCER THERAPY)

M

ORGANISATION IDENTIFIER (CODE OF PROVIDER)

CLINICAL STATUS

To carry the clinical status details.Oneoccurrence of this group is required. 

Mandation

Data Elements

M

PRIMARY DIAGNOSIS (ICD AT START SYSTEMIC ANTI-CANCER THERAPY)

And/Or

MORPHOLOGY (ICD-O AT START SYSTEMIC ANTI-CANCER THERAPY)

O

DIAGNOSIS (SNOMED CT)

REGIMEN

To carry details of the Systemic Anti-Cancer Drug Regimen.Oneoccurrence of this group is permitted. 

Mandation

Data Elements

R

ADJUNCTIVE THERAPY TYPE

R

SYSTEMIC ANTI-CANCER THERAPY DRUG REGIMEN TREATMENT INTENT

M

SYSTEMIC ANTI-CANCER THERAPY DRUG REGIMEN ACRONYM

R

PERSON HEIGHT IN METRES (START OF SYSTEMIC ANTI-CANCER THERAPY DRUG REGIMEN)

R

PERSON WEIGHT (START OF SYSTEMIC ANTI-CANCER THERAPY DRUG REGIMEN)

R

PERFORMANCE STATUS (ADULT START OF SYSTEMIC ANTI-CANCER THERAPY DRUG REGIMEN)

R

CO-MORBIDITY ADJUSTMENT INDICATOR

R

DECISION TO TREAT DATE (SYSTEMIC ANTI-CANCER THERAPY DRUG REGIMEN)

M

START DATE (SYSTEMIC ANTI-CANCER THERAPY DRUG REGIMEN)

R

CLINICAL TRIAL INDICATOR

CYCLE

To carry details of each Systemic Anti-Cancer Therapy Cycle.Multiple occurrences of this group are permitted. One for eachSystemic Anti-Cancer Therapy Cycle.

Mandation

Data Elements

R

SYSTEMIC ANTI-CANCER THERAPY DRUG CYCLE IDENTIFIER

M

START DATE (SYSTEMIC ANTI-CANCER THERAPY DRUG CYCLE)

R

PERSON WEIGHT (START OF SYSTEMIC ANTI-CANCER THERAPY DRUG CYCLE)

R

PERFORMANCE STATUS (ADULT START OF SYSTEMIC ANTI-CANCER THERAPY DRUG CYCLE)

DRUG DETAILS

To carry details of the Systemic Anti-Cancer Therapy Drugs for the patients treatment.Multiple occurrences of this group are permitted.One for eachSystemic Anti-Cancer Therapy Drug.

Mandation

Data Elements

M

SYSTEMIC ANTI-CANCER THERAPY DRUG NAME

P

SYSTEMIC ANTI-CANCER THERAPY DRUG (SNOMED CT DM+D)

R

SYSTEMIC ANTI-CANCER THERAPY ACTUAL DOSE

R

UNIT OF MEASUREMENT (SYSTEMIC ANTI-CANCER THERAPY)

R

OTHER UNIT OF MEASUREMENT DESCRIPTION (SYSTEMIC ANTI-CANCER THERAPY)

O

UNIT OF MEASUREMENT (SNOMED CT DM+D)

R

SYSTEMIC ANTI-CANCER THERAPY DRUG ROUTE OF ADMINISTRATION

O

ROUTE OF ADMINISTRATION (SNOMED CT DM+D)

M

SYSTEMIC ANTI-CANCER THERAPY ADMINISTRATION DATE

R

ORGANISATION IDENTIFIER (OF SYSTEMIC ANTI-CANCER THERAPY ADMINISTRATION)

OUTCOME

To carry details of the outcome applicable to the patient's treatment.Oneoccurrence of this group is permitted.

Mandation

Data Elements

R

SYSTEMIC ANTI-CANCER THERAPY DRUG REGIMEN MODIFICATION INDICATOR (DOSE REDUCTION)

R

SYSTEMIC ANTI-CANCER THERAPY CURATIVE TREATMENT COMPLETED AS PLANNED INDICATOR

R

SYSTEMIC ANTI-CANCER THERAPY CURATIVE TREATMENT NOT COMPLETED OUTCOME REASON

R

OTHER SYSTEMIC ANTI-CANCER THERAPY CURATIVE TREATMENT NOT COMPLETED OUTCOME REASON

R

SYSTEMIC ANTI-CANCER THERAPY NON CURATIVE TREATMENT PATIENT BENEFIT INDICATOR

P

SYSTEMIC ANTI-CANCER THERAPY TOXICITY MODIFICATION INDICATOR

Also Known As

This data set is also known by these names:

Context Alias
Schema SACT
Short name Systemic Anti-Cancer Therapy